0001104659-23-046987.txt : 20230419 0001104659-23-046987.hdr.sgml : 20230419 20230419081029 ACCESSION NUMBER: 0001104659-23-046987 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230417 FILED AS OF DATE: 20230419 DATE AS OF CHANGE: 20230419 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Matthews Andrea CENTRAL INDEX KEY: 0001973349 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37467 FILM NUMBER: 23828513 MAIL ADDRESS: STREET 1: C/O ASTRIA THERAPEUTICS, INC. STREET 2: 75 STATE STREET, SUITE 1400 CITY: BOSTON STATE: MA ZIP: 02109 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Astria Therapeutics, Inc. CENTRAL INDEX KEY: 0001454789 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 75 STATE STREET STREET 2: SUITE 1400 CITY: BOSTON STATE: MA ZIP: 02109 BUSINESS PHONE: 617-349-1971 MAIL ADDRESS: STREET 1: 75 STATE STREET STREET 2: SUITE 1400 CITY: BOSTON STATE: MA ZIP: 02109 FORMER COMPANY: FORMER CONFORMED NAME: CATABASIS PHARMACEUTICALS INC DATE OF NAME CHANGE: 20090127 4 1 tm2313135-2_4seq1.xml OWNERSHIP DOCUMENT X0407 4 2023-04-17 0 0001454789 Astria Therapeutics, Inc. ATXS 0001973349 Matthews Andrea C/O ASTRIA THERAPEUTICS, INC. 75 STATE STREET, SUITE 1400 BOSTON MA 02109 0 1 0 0 Chief Business Officer 0 Stock Option (Right to Buy) 10.82 2023-04-17 4 A 0 20000 0 A 2033-04-16 Common Stock 20000 20000 D This option was granted on April 17, 2023 and is subject to vesting over a four-year period, with 25% of the 20,000 shares underlying the option upon grant vesting on the first anniversary of April 17, 2023 and the remainder vesting over the ensuing three years in equal monthly installments. /s/ Ben Harshbarger, as attorney-in-fact for Andrea Matthews 2023-04-19